Antenatal Corticosteroid Therapy for Preterm Delivery

Standard Dosing Protocol

• The Society for Maternal-Fetal Medicine recommends administering betamethasone 12 mg intramuscularly as two doses given 24 hours apart for pregnancies at 24-34 weeks gestation at risk of preterm delivery, with a GRADE 1A recommendation strength 1, 2, 3
• The American College of Obstetricians and Gynecologists endorses betamethasone 12 mg intramuscularly, two doses 24 hours apart, for gestational ages between 24 0/7 and 34 6/7 weeks 1, 2, 3

Clinical Benefits

• Betamethasone administration substantially reduces the need for respiratory support (11.6% vs 14.4%; RR 0.80) 1, 3
• Betamethasone administration substantially reduces severe respiratory morbidity (8.1% vs 12.1%; RR 0.67) 1, 3
• Betamethasone administration reduces death, respiratory distress syndrome, intraventricular hemorrhage, and sepsis 3, 4

Important Contraindications and Cautions

• The Society for Maternal-Fetal Medicine recommends not administering antenatal corticosteroids in pregnant patients with preegestational diabetes mellitus, as it significantly increases the risk of neonatal hypoglycemia 1, 2
• The American College of Obstetricians and Gynecologists advises against administering antenatal corticosteroids in patients with a low likelihood of delivery before 37 weeks 1, 2

Common Pitfalls to Avoid

• Timing of administration is crucial, with maximum benefit occurring when delivery happens 24 hours to 7 days after administration 1
• A single course of antenatal corticosteroids is recommended; routine repeat or "rescue" courses are not advised in this gestational age range 1
• Neonatal hypoglycemia monitoring is necessary, as betamethasone increases the risk, although 93% of cases resolve within 24 hours and are mild and self-limited 3